GlassScriptPhysician profile
Michael R Zaragoza
NPI 1205821881
$6,189.18
in general payments reported to CMS, 2019-2025
50 companies · $905 in 2025
The $905 reported for 2025 was more than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,169 · 2020: $526 · 2021: $138 · 2022: $799 · 2023: $1,296 · 2024: $1,356 · 2025: $905.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,357 · Education: $200.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,356.90 |
| Education | $199.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $1,010.13 | 2019-2025 | Xtandi, Myrbetriq |
| Sumitomo Pharma America, INC. | $659.55 | 2023-2025 | Gemtesa, Orgovyx |
| Janssen Biotech, INC. | $559.05 | 2019-2025 | Erleada, Akeega |
| Abbvie INC. | $399.46 | 2019-2025 | Botox, Lupron Depot |
| Bayer Healthcare Pharmaceuticals INC. | $279.73 | 2020-2025 | |
| Pfizer INC. | $231.60 | 2019-2025 | |
| Ferring Pharmaceuticals INC. | $187.25 | 2019-2025 | Adstiladrin |
| Teleflex LLC | $168.33 | 2022-2025 | Urolift, Barrigel |
| Progenics Pharmaceuticals, INC. | $168.17 | 2023-2025 | Pylarify |
| Laborie Medical Technologies Corp. | $161.36 | 2022-2024 | Optilume Bph Drug Coated Balloon Catheter |
| Amgen INC. | $147.36 | 2019-2022 | |
| Procept Biorobotics Corporation | $133.76 | 2023-2025 | Aquabeam System, Aquabeam Robotic System |
| Verity Pharmaceuticals INC. | $129.39 | 2022-2025 | Trelstar |
| Boston Scientific Corporation | $129.21 | 2019-2020 | |
| Merck Sharp & Dohme LLC | $128.51 | 2022-2025 | Keytruda, Keytruda Qlex, Lynparza |
Show all 50 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Zaragoza listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.